SZUK.F Stock Overview

Primarily engages in the distribution of pharmaceuticals in Japan and internationally. More details

SZUK.F fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	0/6
Past Performance	4/6
Financial Health	6/6
Dividends	5/6

Rewards

Trading at 12.6% below our estimate of its fair value

Earnings grew by 45.8% over the past year

Pays a reliable dividend of 2%

Risk Analysis

Earnings are forecast to decline by an average of 2.4% per year for the next 3 years

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Suzuken Co., Ltd. Competitors

Patterson Companies

NasdaqGS:PDCO

US$2.7b

Henry Schein

NasdaqGS:HSIC

US$8.6b

Cardinal Health

NYSE:CAH

US$28.3b

Cencora

NYSE:COR

US$43.7b

Price History & Performance

Summary of share price highs, lows and changes for Suzuken
Historical stock prices
Current Share Price	JP¥30.30
52 Week High	JP¥30.30
52 Week Low	JP¥28.89
Beta	0
1 Month Change	0%
3 Month Change	4.88%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-14.65%

Recent updates

Shareholder Returns

	SZUK.F	US Healthcare	US Market
7D	0%	-4.1%	-2.4%
1Y	n/a	-10.2%	23.3%

Return vs Industry: Insufficient data to determine how SZUK.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how SZUK.F performed against the US Market.

Price Volatility

Is SZUK.F's price volatile compared to industry and market?
SZUK.F volatility
SZUK.F Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: SZUK.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SZUK.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1932	13,086	Shigeru Asano	www.suzuken.co.jp

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies.

Suzuken Co., Ltd. Fundamentals Summary

How do Suzuken's earnings and revenue compare to its market cap?
SZUK.F fundamental statistics
Market cap	US$2.71b
Earnings (TTM)	US$213.08m
Revenue (TTM)	US$16.66b

12.7x

P/E Ratio

0.2x

P/S Ratio

Is SZUK.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SZUK.F income statement (TTM)
Revenue	JP¥2.40t
Cost of Revenue	JP¥2.21t
Gross Profit	JP¥187.93b
Other Expenses	JP¥157.29b
Earnings	JP¥30.64b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 12, 2024

Earnings per share (EPS)	394.59
Gross Margin	7.85%
Net Profit Margin	1.28%
Debt/Equity Ratio	0%

How did SZUK.F perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

21%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/09/24 06:58
End of Day Share Price	2024/06/28 00:00
Earnings	2024/06/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Suzuken Co., Ltd. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Atsushi Seki	Barclays
Ritsuo Watanabe	BofA Global Research
Hidemaru Yamaguchi	Citigroup Global Markets Japan Inc.